Immunotherapy protocol of culturing leukocytes in the presence of interleukin-2 in a hollow fiber cartridge
AssigneeEndotronics, Inc.
InventorsGeorgiann B. Melink, Raji A. Shankar
Life of this patent
Estimating the term…
Abstract
An immunotherapy protocol in which leukocytes are cultured in the presence of interleukin-2 in a hollow fiber cartridge perfusion system for at least four days to achieve a harvest yield of at least 100% of leukocytes with respect to the number of cells initially present in the hollow cartridge, and where the leukocytes have a lytic activity at least equal to that of cells grown in a static culturing system and where the lytic activity of the cells following the culture period in the hollow fiber is at least equal to cells grown in a static culturing system.
Claims5
An immunotherapy protocol comprising:
- culturing leukocytes at a high density of about 8.times.10.sup.7 cells per ml in the presence of recombinant interleukin-2, in a hollow fiber cartridge for at least four days to obtain a cell harvest having a yield of at least 100% with respect to the number of cells initially present in the hollow fiber cartridge, wherein the cultured leukocytes have a lyric activity approximately equal to or greater than that of leukocytes cultured in a static culturing system, and administering said cultured leukocytes to a patient in need of said immunotherapy.
Dependencies are inferred from the claim text.